Endothelial cell‐specific redox gene modulation inhibits angiogenesis but promotes B16F0 tumor growth in mice
Authors:
Open Access
- 26 October 2019
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 33 (12) , 14147-14158
Abstract
Glutaredoxin‐1 (Glrx) is a small cytosolic enzyme that removes S ‐glutathionylation, glutathione adducts of protein cysteine residues, thus modulating redox signaling and gene transcription. Although Glrx up‐regulation prevented endothelial cell (EC) migration and global Glrx transgenic mice had impaired ischemic vascularization, the effects of cell‐specific Glrx overexpression remained unknown. Here, we examined the role of EC‐specific Glrx up‐regulation in distinct models of angiogenesis; namely, hind limb ischemia and tumor angiogenesis. EC‐specific Glrx transgenic (EC‐Glrx TG) overexpression in mice significantly impaired EC migration in Matrigel implants and hind limb revascularization after femoral artery ligation. Additionally, ECs migrated less into subcutaneously implanted B16F0 melanoma tumors as assessed by decreased staining of EC markers. Despite reduced angiogenesis, EC‐Glrx TG mice unexpectedly developed larger tumors compared with control mice. EC‐Glrx TG mice showed higher levels of VEGF‐A in the tumors, indicating hypoxia, which may stimulate tumor cells to form vascular channels without EC, referred to as vasculogenic mimicry. These data suggest that impaired ischemic vascularization does not necessarily associate with suppression of tumor growth, and that antiangiogenic therapies may be ineffective for melanoma tumors because of their ability to implement vasculogenic mimicry during hypoxia.—Yura, Y., Chong, B. S. H., Johnson, R. D., Watanabe, Y., Tsukahara, Y., Ferran, B., Murdoch, C. E., Behring, J. B., McComb, M. E., Costello, C. E., Janssen‐Heininger, Y. M. W., Cohen, R. A., Bachschmid, M. M., Matsui, R. Endothelial cell‐specific redox gene modulation inhibits angiogenesis but promotes B16F0 tumor growth in mice. FASEB J. 33, 14147‐14158 (2019). www.fasebj.orgKeywords
Funding Information
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01 HL133013, T32 HL70024, R37 HL104017, HHSN268201000031C)
- National Institutes of Health
- National Institute on Aging (R03 AG051857)
- National Center for Advancing Translational Sciences (1UL1 TR001430)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK103750)
- American Heart Association (16GRNT27660006)
This publication has 57 references indexed in Scilit:
- Vasculogenic Mimicry of HT1080 Tumour Cells In Vivo: Critical Role of HIF-1α-Neuropilin-1 AxisPLOS ONE, 2012
- Hypoxia Negatively Regulates Antimetastatic PEDF in Melanoma Cells by a Hypoxia Inducible Factor-Independent, Autophagy Dependent MechanismPLOS ONE, 2012
- Regulation of Cell Physiology and Pathology by Protein S-Glutathionylation: Lessons Learned from the Cardiovascular SystemAntioxidants & Redox Signaling, 2012
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxiaProceedings of the National Academy of Sciences, 2012
- Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant ResponsesScience, 2011
- VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor GrowthCancer Research, 2011
- Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout miceFree Radical Biology and Medicine, 2010
- Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of FasJournal of Cell Biology, 2009
- Redox-based regulation of signal transduction: Principles, pitfalls, and promisesFree Radical Biology and Medicine, 2008
- Modulation of Glutaredoxin-1 Expression in a Mouse Model of Allergic Airway DiseaseAmerican Journal of Respiratory Cell and Molecular Biology, 2007